Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PF-08046032 in people with advanced cancers; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma
• Diffuse Large B-cell Lymphoma
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Peripheral T-cell Lymphoma

Drugs mentioned

• PF-08046032

Snippet

Sponsor: Pfizer | Conditions: Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING